| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C0002085> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C0063717> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C0752046> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34353696_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Vanda Pharmaceuticals Inc., 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037, United States. Electronic address: sandra.smieszek@vandapharma.com.\', \'Vanda Pharmaceuticals Inc., 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037, United States.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Polymeropoulos_Christos_M> <https://research.tib.eu/covid-19/entity/Polymeropoulos_Mihael_H> <https://research.tib.eu/covid-19/entity/Polymeropoulos_Vasilios_M> <https://research.tib.eu/covid-19/entity/Przychodzen_Bartlomiej_P> <https://research.tib.eu/covid-19/entity/Smieszek_Sandra_P>
?:doi	<https://research.tib.eu/covid-19/entity/S1043-4666%2821%2900249-010.1016/j.cyto.2021.155662>
?:doi	S1043-4666(21)00249-010.1016/j.cyto.2021.155662
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial%2C_Phase_III> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Randomized_Controlled_Trial> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Cytokine
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34353696>
?:pmid	<https://research.tib.eu/covid-19/entity/34353696>
?:pmid	34353696
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.433
?:rankingScore_hIndex	99
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0021760_ASSOCIATED_WITH_C0032285> <https://research.tib.eu/covid-19/entity/C0030705_LOCATION_OF_C1334122>
?:title	Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients\'.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34353696>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34353696>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all